The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs. All eventually passed muster.
Related Posts
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research
When Dr. Monica M. Bertagnolli moved into the director’s suite at the National Institutes of Health, she brought with her…
Trump Budget Eliminates Funding for Crucial Global Vaccination Programs
The spending proposal terminates support of health programs that, according to the proposal, “do not make Americans safer.”
At Animal Hospitals, Social Workers Offer Care for the Humans
Amy Conroy sat alone in a veterinary exam room, hands clutching a water bottle, eyes blinking back tears. Her 16-year-old…